Furthermore, Hu et al.50 demonstrated that FTO transactivation and m6A demethylation on mRNA of lipogenic genes induced lipogenic gene activation and lipid accumulation during NAFLD and were mediated by glucocorticoid receptor. The gene discussed is FTO; the disease is metabolic dysfunction-associated steatotic liver disease.